Value Investing Articles

Results 11 - 20 of 50 : Previous 1 2 3 4 5 Next

August 19, 2015

8 Things You Probably Don't Know About Johnson & Johnson

There's so much more to Johnson & Johnson than you realize. Here are eight facts about the healthcare conglomerate that you may not already be aware of.

August 18, 2015

Something Big Is Happening With Big Pharma

You probably missed it, but a big shift is underway in Big Pharma stocks.

August 17, 2015

5 Things Coach Management Wants You to Know

Luxury goods maker says the turnaround is under way and only patience is needed to reap the benefits.

August 13, 2015

5 Things GlaxoSmithKline Plc Wants You to Know

GlaxoSmithKline may have surpassed Wall Street's profit expectations in Q2, but unless you really listened to what its management team had to say during the conference call you probably missed a lot of key points. Here are five of them.

August 13, 2015

5 Things Pfizer inc. Wants You to Know

Pfizer handily surpassed Wall Street's earnings estimates in the second quarter, but if you didn't dig past the headline numbers, then you likely missed these five important points in the company's conference call.

August 12, 2015

5 Things Merck Wants You to Know

Pharmaceutical giant Merck may have topped Wall Street's profit expectations in Q2, but these are the really important points that Merck's management team wants its investors to know.

August 12, 2015

The Best Deals in Under-the-Radar Stocks

Anyone can buy a household brand-name stock, but sometimes the best gems fly under Wall Street's radar.

August 10, 2015

5 Things Johnson & Johnson Wants You to Know

Johnson & Johnson topped Wall Street's estimates in Q2, but headline figures usually don't tell you the full story. Here are five key points J&J's management team wants you to take away from its conference call.

August 06, 2015

3 Reasons Behind Amgen's 15% Gain in July

Amgen shares soared in July on the heels of three major catalysts. Find out if Amgen has the tools to motor even higher or if you should consider cashing in your chips.

August 05, 2015

3 Reasons GlaxoSmithKline Investors Can Breathe a Sigh of Relief

U.K.-based GlaxoSmithKline surpasses Wall Street's profit expectations in the second quarter, and more importantly provides three reasons why investors may be able to stop worrying about its near-term prospects.

Results 11 - 20 of 50 : Previous 1 2 3 4 5 Next